Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues	$ 2,144,535	$ 3,095,080	$ 7,973,973	$ 9,487,055
Reimbursement revenues	83,342	233,137	493,168	879,181
Total revenues	2,227,877	3,328,217	8,467,141	10,366,236
Cost of services	1,328,406	1,633,024	4,602,469	5,270,148
Cost of reimbursement revenues	83,342	233,137	493,168	879,181
Total cost of services	1,411,748	1,866,161	5,095,637	6,149,329
Gross profit	816,129	1,462,056	3,371,504	4,216,907
Operating expenses
Research and development	376,595	414,913	1,179,760	1,171,589
Sales and marketing	347,977	314,991	1,135,782	961,714
General and administrative	747,708	684,052	2,511,330	2,202,368
Depreciation and amortization	88,863	101,393	275,730	320,003
Total operating expenses	1,561,143	1,515,349	5,102,602	4,655,674
Operating loss	(745,014)	(53,293)	(1,731,098)	(438,767)
Other income (expense)
Other income	1,030	1,044	5,381	2,174
Other expense	(6,680)	(7,206)	(17,561)	(12,920)
Unrealized (loss) gain on change in fair value of the derivative liabilities	(658)	(19,794)	13,295	(306,247)
Total other (expense) income	(6,308)	(25,956)	1,115	(316,993)
Net loss	(751,322)	(79,249)	(1,729,983)	(755,760)
Preferred stock deemed dividend	0	0	0	1,806,919
Preferred stock dividends	42,000	42,000	126,000	95,333
Net loss available to common stockholders	$ (793,322)	$ (121,249)	$ (1,855,983)	$ (2,658,012)
Weighted average basic and diluted shares Outstanding (in shares)	2,979,952	2,974,776	2,979,952	2,960,868
Basic and diluted loss per share (in dollars per share)	$ (0.27)	$ (0.04)	$ (0.62)	$ (0.90)